Literature DB >> 19336882

Generation and characterization of monoclonal antibody to ginsenoside rg3.

Eun Ji Joo1, Young Wan Ha, Heungsop Shin, Sung Ho Son, Yeong Shik Kim.   

Abstract

While studying the mechanism of ginsenoside Rg3 (G-Rg3) on tumor inhibition, we produced monoclonal antibody to G-Rg3 for more specific investigation. We immunized Balb/c mice to G-Rg3 conjugated bovine serum albumin (BSA) by intraperitoneal injection and hybridized splenocytes from those immunized mice and myeloma cells. From those fusion cell lines, we selected productive monoclonal clones and obtained culture media containing monoclonal antibody to G-Rg3. After purification, we performed enzyme-linked immunosorbent assay (ELISA) to verify the sensitivity and specificity of the antibody. When compared with G-Rh2 having a very similar structure as a metabolite of G-Rg3, the antibody worked only with G-Rg3 in a concentration-dependent manner. We confirmed that the monoclonal antibody to G-Rg3 can be applied to immunocytochemistry for detection of the treated G-Rg3 inside A549 human lung adenocarcinomas. Thus, the monoclonal antibody to G-Rg3 would be a useful tool for measuring the bioactivity of G-Rg3 in various fields.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19336882     DOI: 10.1248/bpb.32.548

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  10 in total

Review 1.  Plant triterpenoid saponins: biosynthesis, in vitro production, and pharmacological relevance.

Authors:  Tanya Biswas; Upendra N Dwivedi
Journal:  Protoplasma       Date:  2019-07-11       Impact factor: 3.356

2.  A sensitive indirect competitive enzyme-linked immunosorbent assay for the detection of sarsasapogenin in rat plasma.

Authors:  Jing Wang; Ji-hua Liu; Xu Guo; Jian Zhang; Bo-yang Yu
Journal:  Acta Pharmacol Sin       Date:  2010-08       Impact factor: 6.150

Review 3.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

4.  Ginsenoside Rg3 enhances the inhibitory effects of chemotherapy on esophageal squamous cell carcinoma in mice.

Authors:  Liang Chang; Bingjie Huo; Yalei Lv; Yudong Wang; Wei Liu
Journal:  Mol Clin Oncol       Date:  2014-07-23

5.  Pharmacology of ginsenosides: a literature review.

Authors:  Kar Wah Leung; Alice Sze-Tsai Wong
Journal:  Chin Med       Date:  2010-06-11       Impact factor: 5.455

6.  Identification and confirmation of 14-3-3 ζ as a novel target of ginsenosides in brain tissues.

Authors:  Feiyan Chen; Lin Chen; Weifeng Liang; Zhengguang Zhang; Jiao Li; Wan Zheng; Zhu Zhu; Jiapeng Zhu; Yunan Zhao
Journal:  J Ginseng Res       Date:  2020-12-29       Impact factor: 6.060

7.  Electrospun poly(L-lactide) fiber with ginsenoside rg3 for inhibiting scar hyperplasia of skin.

Authors:  Wenguo Cui; Liying Cheng; Changmin Hu; Haiyan Li; Yuguang Zhang; Jiang Chang
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

8.  Immunogenic Cell Death Induced by Ginsenoside Rg3: Significance in Dendritic Cell-based Anti-tumor Immunotherapy.

Authors:  Keum-Joo Son; Ki Ryung Choi; Seog Jae Lee; Hyunah Lee
Journal:  Immune Netw       Date:  2016-02-25       Impact factor: 6.303

Review 9.  Enzyme-linked immunosorbent assay for the quantitative/qualitative analysis of plant secondary metabolites.

Authors:  Seiichi Sakamoto; Waraporn Putalun; Sornkanok Vimolmangkang; Waranyoo Phoolcharoen; Yukihiro Shoyama; Hiroyuki Tanaka; Satoshi Morimoto
Journal:  J Nat Med       Date:  2017-11-21       Impact factor: 2.343

10.  Protein target identification of ginsenosides in skeletal muscle tissues: discovery of natural small-molecule activators of muscle-type creatine kinase.

Authors:  Feiyan Chen; Kexuan Zhu; Lin Chen; Liufeng Ouyang; Cuihua Chen; Ling Gu; Yucui Jiang; Zhongli Wang; Zixuan Lin; Qiang Zhang; Xiao Shao; Jianguo Dai; Yunan Zhao
Journal:  J Ginseng Res       Date:  2019-03-07       Impact factor: 6.060

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.